Janus Henderson Group PLC Fibrogen Inc Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.49 - $20.59 $1.09 Million - $9.05 Million	-439,459 Reduced 90.3%	47,193 $127,000
Q1 2023 May 15, 2023	BUY	$15.95 - $25.18 $1.77 Million - $2.79 Million	110,808 Added 29.48%	486,652 $9.08 Million
Q4 2022 Feb 14, 2023	BUY	$13.27 - $17.73 $4.77 Million - $6.37 Million	359,198 Added 2157.86%	375,844 $6.02 Million
Q3 2022 Nov 14, 2022	SELL	$11.4 - $14.6 $262 - $335	-23 Reduced 0.14%	16,646 $217,000
Q2 2022 Aug 15, 2022	BUY	$7.94 - $12.96 $230 - $375	29 Added 0.17%	16,669 $176,000
Q1 2022 May 16, 2022	BUY	$12.02 - $16.79 $36 - $50	3 Added 0.02%	16,640 $200,000
Q4 2021 Feb 14, 2022	BUY	$9.93 - $15.39 $165,205 - $256,043	16,637 New	16,637 $235,000
Q3 2021 Nov 16, 2021	SELL	$10.18 - $26.64 $12.5 Million - $32.6 Million	-1,224,474 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$18.57 - $35.68 $38.3 Million - $73.5 Million	-2,059,793 Reduced 62.72%	1,224,474 $32.6 Million
Q1 2021 May 17, 2021	SELL	$31.0 - $55.72 $3.58 Million - $6.43 Million	-115,417 Reduced 3.39%	3,284,267 $114 Million
Q4 2020 Feb 16, 2021	BUY	$37.09 - $48.97 $3.36 Million - $4.44 Million	90,719 Added 2.74%	3,399,684 $126 Million
Q3 2020 Nov 16, 2020	BUY	$40.47 - $45.5 $4.2 Million - $4.72 Million	103,815 Added 3.24%	3,308,965 $136 Million
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $4.04 Million - $5.32 Million	124,164 Added 4.03%	3,205,150 $130 Million
Q1 2020 May 14, 2020	BUY	$23.3 - $45.96 $10.3 Million - $20.3 Million	441,296 Added 16.72%	3,080,986 $107 Million
Q4 2019 Feb 18, 2020	SELL	$34.58 - $48.06 $1.13 Million - $1.57 Million	-32,614 Reduced 1.22%	2,639,690 $113 Million
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $6.35 Million - $8.32 Million	171,737 Added 6.87%	2,672,304 $98.8 Million
Q2 2019 Jul 31, 2019	BUY	$35.13 - $55.53 $10.3 Million - $16.2 Million	291,808 Added 13.21%	2,500,567 $113 Million
Q1 2019 Apr 30, 2019	BUY	$42.83 - $59.91 $20.3 Million - $28.3 Million	473,042 Added 27.25%	2,208,759 $120 Million
Q4 2018 Feb 06, 2019	BUY	$37.97 - $60.16 $19.6 Million - $31.1 Million	516,476 Added 42.36%	1,735,717 $80.3 Million
Q3 2018 Nov 09, 2018	SELL	$56.3 - $67.25 $8.82 Million - $10.5 Million	-156,742 Reduced 11.39%	1,219,241 $74.1 Million
Q2 2018 Aug 10, 2018	SELL	$44.9 - $64.95 $27.1 Million - $39.2 Million	-603,369 Reduced 30.48%	1,375,983 $86.1 Million
Q1 2018 May 14, 2018	SELL	$45.35 - $61.65 $684,059 - $929,928	-15,084 Reduced 0.76%	1,979,352 $91.4 Million
Q4 2017 Feb 09, 2018	BUY	$41.95 - $60.1 $25.4 Million - $36.4 Million	605,715 Added 43.62%	1,994,436 $94.5 Million
Q3 2017 Nov 14, 2017	SELL	$33.4 - $53.9 $804,205 - $1.3 Million	-24,078 Reduced 1.7%	1,388,721 $0
Q2 2017 Aug 17, 2017	BUY	N/A	1,412,799	1,412,799 $45.6 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account